Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46


Clinical presentation, management, and outcomes in the Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF) registry.

Vora A, Kapoor A, Nair M, Lokhandwala Y, Narsimhan C, Ravikishore AG, Dwivedi SK, Namboodiri N, Hygriv R, Saxena A, Nabar A, Garg S, Bardoloi N, Yadav R, Nambiar A, Pandurangi U, Jhala D, Naik A, Nagmallesh, Rajagopal S, Selvaraj R, Arora V, Thachil A, Thomas J, Panicker G.

Indian Heart J. 2017 Jan - Feb;69(1):43-47. doi: 10.1016/j.ihj.2016.06.006.


Left atrial appendage closure: outcomes and challenges.

Suradi HS, Hijazi ZM.

Neth Heart J. 2017 Feb;25(2):143-151. doi: 10.1007/s12471-016-0929-0. Review.


Lifetime risk of stroke in young-aged and middle-aged Chinese population: the Chinese Multi-Provincial Cohort Study.

Wang Y, Liu J, Wang W, Wang M, Qi Y, Xie W, Li Y, Sun J, Liu J, Zhao D.

J Hypertens. 2016 Dec;34(12):2434-2440.


A comparison of the CHARGE-AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study.

Christophersen IE, Yin X, Larson MG, Lubitz SA, Magnani JW, McManus DD, Ellinor PT, Benjamin EJ.

Am Heart J. 2016 Aug;178:45-54. doi: 10.1016/j.ahj.2016.05.004.


Preoperative heart rate and myocardial injury after non-cardiac surgery: results of a predefined secondary analysis of the VISION study.

Abbott TE, Ackland GL, Archbold RA, Wragg A, Kam E, Ahmad T, Khan AW, Niebrzegowska E, Rodseth RN, Devereaux PJ, Pearse RM.

Br J Anaesth. 2016 Aug;117(2):172-81. doi: 10.1093/bja/aew182.


Atrial Fibrillation Genetics: Is There a Practical Clinical Value Now or in the Future?

Hucker WJ, Saini H, Lubitz SA, Ellinor PT.

Can J Cardiol. 2016 Nov;32(11):1300-1305. doi: 10.1016/j.cjca.2016.02.032. Review.


Atrial fibrillation in patients with diabetes: molecular mechanisms and therapeutic perspectives.

De Sensi F, De Potter T, Cresti A, Severi S, Breithardt G.

Cardiovasc Diagn Ther. 2015 Oct;5(5):364-73. doi: 10.3978/j.issn.2223-3652.2015.06.03. Review.


Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis.

Shiffman D, Perez MV, Bare LA, Louie JZ, Arellano AR, Devlin JJ.

BMC Cardiovasc Disord. 2015 Sep 29;15:104. doi: 10.1186/s12872-015-0100-7.


A Review of Current Diagnosis, Investigation, and Management of Acute Coronary Syndromes in Elderly Patients.

McCune C, McKavanagh P, Menown IB.

Cardiol Ther. 2015 Dec;4(2):95-116. doi: 10.1007/s40119-015-0047-x.


Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementation.

Camm AJ, Pinto FJ, Hankey GJ, Andreotti F, Hobbs FD; Writing Committee of the Action for Stroke Prevention alliance..

Europace. 2015 Jul;17(7):1007-17. doi: 10.1093/europace/euv068. Review.


Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.

Soliman EZ, Lopez F, O'Neal WT, Chen LY, Bengtson L, Zhang ZM, Loehr L, Cushman M, Alonso A.

Circulation. 2015 May 26;131(21):1843-50. doi: 10.1161/CIRCULATIONAHA.114.014145.


Down-regulation of the small conductance calcium-activated potassium channels in diabetic mouse atria.

Yi F, Ling TY, Lu T, Wang XL, Li J, Claycomb WC, Shen WK, Lee HC.

J Biol Chem. 2015 Mar 13;290(11):7016-26. doi: 10.1074/jbc.M114.607952.


Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, Creager MA, Eckel RH, Elkind MS, Fornage M, Goldstein LB, Greenberg SM, Horvath SE, Iadecola C, Jauch EC, Moore WS, Wilson JA; American Heart Association Stroke Council.; Council on Cardiovascular and Stroke Nursing.; Council on Clinical Cardiology.; Council on Functional Genomics and Translational Biology.; Council on Hypertension..

Stroke. 2014 Dec;45(12):3754-832. doi: 10.1161/STR.0000000000000046.


Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke.

Tada H, Shiffman D, Smith JG, Sjögren M, Lubitz SA, Ellinor PT, Louie JZ, Catanese JJ, Engström G, Devlin JJ, Kathiresan S, Melander O.

Stroke. 2014 Oct;45(10):2856-62. doi: 10.1161/STROKEAHA.114.006072.


Atrial fibrillation as a marker of occult cancer.

Ostenfeld EB, Erichsen R, Pedersen L, Farkas DK, Weiss NS, Sørensen HT.

PLoS One. 2014 Aug 13;9(8):e102861. doi: 10.1371/journal.pone.0102861.


Venous thromboembolism increases the risk of atrial fibrillation: the Tromso study.

Hald EM, Enga KF, Løchen ML, Mathiesen EB, Njølstad I, Wilsgaard T, Braekkan SK, Hansen JB.

J Am Heart Assoc. 2014 Jan 2;3(1):e000483. doi: 10.1161/JAHA.113.000483.

Supplemental Content

Support Center